Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
3.220
+0.110 (3.54%)
At close: Nov 4, 2024, 4:00 PM
3.140
-0.080 (-2.48%)
After-hours: Nov 4, 2024, 4:01 PM EST
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $87.12 million as of November 4, 2024. Its market cap has increased by 208.93% in one year.
Market Cap
87.12M
Enterprise Value
-19.26M
1-Year Change
208.93%
Ranking
Category
Stock Price
$3.22
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $87.12M, an increase of 836.75%. That is a compound annual growth rate of 30.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 84.10M | -39.45% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 89.59M |
| So-Young International | 89.00M |
| I-Mab | 88.76M |
| Chimerix | 88.74M |
| Monopar Therapeutics | 87.22M |
| Agenus | 87.04M |
| WORK Medical Technology Group LTD | 86.82M |
| Aileron Therapeutics | 86.66M |